New combo before surgery may boost pancreatic cancer outcomes
NCT ID NCT03492671
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving chemotherapy and radiation before surgery can help surgeons remove all of the pancreatic cancer. About 30 adults with resectable pancreatic cancer will receive the drugs gemcitabine and nab-paclitaxel plus targeted radiation, then surgery, then more chemo. The goal is to see if this approach increases the chance of a complete removal and improves survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Loma Linda University Health
RECRUITINGLoma Linda, California, 92354, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test catch pancreatic cancer before It's too late?
- Scientists hunt for clues to prevent a common complication after pancreatic cancer surgery
- New drug THE-0504 enters human testing for tough cancers
- Pancreatic cancer showdown: surgery first or chemo first?
- Blood test could guide pancreatic cancer therapy
- Gut bacteria may forecast surgery risks in pancreatic cancer patients